PHARMACIST’S ROLE IN REPORTING AND PREVENTING MEDICATION ERRORS AT A GENERAL HOSPITAL IN MAKKAH, SAUDI ARABIA
HTML Full TextPHARMACIST’S ROLE IN REPORTING AND PREVENTING MEDICATION ERRORS AT A GENERAL HOSPITAL IN MAKKAH, SAUDI ARABIA
Reema Mashhour Alsharif *, Haneen Badi Alharbi and Khalid R. A. Abdellatif
Department of Clinical Pharmacy, King Faisal Hospital, Makkah, Saudi Arabia.
ABSTRACT: Background: Medication errors significantly impact patient morbidity and mortality. Due to their specialized expertise, pharmacists are essential in detecting and averting these errors. Methods: This study evaluated pharmacists' roles in reporting and preventing medication errors at King Faisal Hospital in Makkah, Saudi Arabia. Using a cross-sectional method, we analyzed medication error reports to understand the rate, causes, and types of errors during the study period. A questionnaire further probed pharmacists' interventions in reducing these errors. Results: Of the 45 pharmacists surveyed (average age: 34.91 ± 3.9 years), 1,738 medication errors were reported between September 2021 and July 2022, peaking in October 2021. Key causes were prescribing errors (26%), dispensing errors (16%), and dosing errors (10%), with the remaining 48% attributed to various other factors. Common interventions included liaising with physicians for emergency order verification, preventing unintended dispensation, and correcting dosing mistakes. Conclusion: Predominant medication errors arose from prescribing, dispensing, dosing, omission, improper dosage, and incorrect frequency. Miscommunication in drug orders, characterized by illegibility or ambiguity, was a major error contributor. Upon detecting errors, pharmacists frequently reported to supervisors, communicated with physicians for clarity, informed responsible parties to correct and prevent repeat occurrences, and championed more training to address these issues proactively.
Keywords: Medication error, Pharmacist intervention, Clinical pharmacist, Prescribing error, Dispensing error, and dosing error
INTRODUCTION: Medication errors are recognized as one of the most prevalent medical mistakes, impacting approximately 1.5 million individuals each year. They stand as the primary cause of adverse events among hospitalized patients 8.
According to the National Coordinating Council for Medical Reporting and Prevention and the World Health Organization (WHO), a medication error is defined as any preventable incident that could result in inappropriate medication use or patient harm while the medication is within the purview of healthcare professionals, patients, or consumers 16.
These errors can be categorized based on when they occur within the prescription cycle: prescribing, supplying, or administering errors 12. Prescribing errors arise when physicians select the incorrect medication for patients, encompassing errors in dosage, quantity, indication, or the use of contraindicated medications 7. Dispensing errors encompass the entire process, from obtaining a prescription at the pharmacy to delivering the dispensed drug to a patient. These errors account for 24% of all medication errors, occurring most frequently with drugs that share similar names or appearances 2. Conversely, administration errors transpire when the medication received by the patient deviates from the prescribed therapy, including improper administration procedures and the provision of faulty or expired products 3-11.
Interventions aimed at preventing medication errors are considered a critical and intricate process, as the treatment of medication errors often demands sophisticated resources 13. One effective intervention involves pharmacists participating in prescription reviews, leading to the detection and avoidance of a significant number of pharmaceutical errors that have the potential to cause severe harm 10. Clinical pharmacists play a pivotal role in ensuring the safe administration of medications 15. In our study, we aimed to pinpoint the pharmacists’ role in reducing medication errors in hospitals.
MATERIALS AND METHODS: This is a cross-sectional study conducted at King Faisal Hospital in Makkah, Saudi Arabia (KSA). The study protocol received approval from the Ministry of Health’s Institutional Review Board in Makkah, part of the Makkah Health Care Cluster, with IRB Number: H-02-K-076- 0522-725. The primary objective of this study is to analyze medication errors reported between September 2021 and July 2022. We aim to assess the rate, causes, and types of medication errors that occurred within the hospital during this specified study period. Additionally, we administered a questionnaire to 45 pharmacists at King Faisal Hospital to identify interventions employed by pharmacists to reduce and prevent medication errors. This questionnaire comprised three sections. The first section gathered demographic information about the participating pharmacists, while the second section delved into the efforts made by pharmacists in the reduction and prevention of medication errors. The third section aimed to identify any barriers encountered in these endeavors (Appendix I).
Prior to conducting this survey, the questionnaire underwent validation using a convenience sample of 30 respondents, who were subsequently excluded from the main study. The questionnaire’s validity and reliability were meticulously evaluated, yielding a Cronbach’s alpha value exceeding 0.7 for all items, including knowledge, barriers, and facilitators. Any data collected before the designated study period was excluded from our analysis.
Data collection was performed using Microsoft Excel software and subsequently prepared for statistical analysis. The statistical analysis was carried out using SPSS 22nd edition. Qualitative data were presented in terms of frequency and percentages and were compared using the Chi-squared (χ²) test. The significance level for this study was set at 0.05.
RESULTS: In the current study, a total of 45 pharmacists participated to investigate their opinions regarding the causes of medication errors and their efforts to prevent them. The participants had a mean age of 34.91±4.5 years. Of the participants, 58% were male and 42% were female. Furthermore, 81.3% of the included pharmacists held a bachelor’s degree, 12.3% held a master’s degree, 3.2% had a diploma, and 3.2% held a Ph.D. degree. The mean number of years of experience as a pharmacist was 8.6 ± 6 years Table 1.
TABLE 1: DEMOGRAPHICS AND EXPERIENCE OF THE INCLUDED PHARMACISTS
Mean | ||
Age | 34.91 ± 4.05 | |
Gender | Male | 26 (58%) |
Female | 19 (42%) | |
Type of your clinical pharmacy degree: | Bachelor | 36 (81.3%) |
Diploma | 1 (3.2%) | |
Masters | 7 (12.3%) | |
PhD | 1 (3.2%) | |
No. of experience years as a clinical pharmacist | 8.6 ± 6 |
Common causes of Medication Error, According to the Pharmacists’ View: Fig. 1 illustrates that the majority of pharmacists (74.2%) strongly agreed on the importance of including specific information in the patient’s medical file.
This information includes the patient’s personal details (e.g., age and sex). Additionally, 61.3% of respondents emphasized the significance of documenting the patient’s medical history, while 71% stressed the importance of prescribing medications using their generic names. Furthermore, 64.5% emphasized the need for clear and proper documentation of dose concentrations in both numeric values and milligrams. Regarding medication interactions, 67.7% of pharmacists expressed a strong agreement with the necessity of checking for potential interactions between prescribed medications. Additionally, 71% of respondents agreed that each prescribed medication should adhere to clinical guidelines. In terms of medication availability, 61.3% agreed that it is essential to inquire about the availability of prescribed medications in their department. Likewise, 64.5% concurred that antimicrobial medications should be prescribed solely in accordance with clinical guidelines. Lastly, 64.5% also agreed that dose adjustments should be made for each medication based on the patient’s health condition.
The most frequently reported causes of medication errors among the included pharmacists, as presented in Table 2, were as follows: prescribing errors (26%), dispensing errors (16%), and dosing errors for certain medications (10%). The remaining 48% of errors were attributed to various other factors, as indicated by the pharmacists’ responses. These included 3.2% for drug interactions, 3.2% for Look-Alike Sound-Alike (LASA) medications, and workforce-related issues. Some pharmacists mentioned specific high-alert medications such as heparin, enoxaparin, potassium chloride (KCL), and human albumin, while others referred to concerns with anti-seizure medications, antibiotic dosing problems, or errors in writing the administration route (e.g., IV instead of IM or vice versa). Additionally, a few pharmacists cited technical IT problems that could contribute to prescribing errors.
FIG. 1: PHARMACISTS’ INTERVENTION DURING THE MEDICATION STAGES
TABLE 2: COMMON CAUSES OF MEDICATION ERROR MENTIONED BY THE PHARMACISTS
Count | % | ||
Mention the most | No double check when entering the order/ not following privilege policy/workload | 1 | 3.2% |
common | |||
medication error | 1) no complete information | 1 | 3.2% |
causes in your | 2) wrong diagnosis or indication | ||
department | 3) bypassing of interactions or duplication | ||
(mention causes) | alerts | ||
Anti-Seizure Medication | 1 | 3.2% | |
Cephalosporin (iv), kcl iv, bacterium | 1 | 3.2% | |
Dosing and route | 1 | 3.2% | |
Dosing of some medication | 9 | 10% | |
Heparin route, Enoxaparin dose, and Human Albumin dose. | 1 | 3.2% | |
Incomplete written prescribed medication | 1 | 3.2% | |
IT problem Wrong entry Change to IM or IV in medication taken s/c | 1 | 3.2% | |
Missing doses, drug, drug interaction, misuse of antibiotics | 1 | 3.2% | |
Prescribing | 21 | 26% | |
dispensing | 10 | 16% | |
Technically, LASA medication, workload | 1 | 3.2% | |
There aren’t any medication errors in my department. | 1 | 3.2% | |
Drug interactions | 1 | 3.2% | |
Wrong dose - wrong frequency- wrong dosage form | 1 | 3.2% | |
Wrong dose, wrong frequency, | 1 | 3.2% | |
Wrong entry | 1 | 3.2% |
In relation to the impact of workforce and standard procedures within drug facilities on medication error occurrence, Fig. 2 provides insights. Approximately half of the pharmacists (51.6%) disagreed with the notion that the number of clinical pharmacists is sufficient to manage the workload. Similarly, almost half (48.4%) disagreed with the idea that other hospital pharmacists adequately support clinical pharmacists in their duties. However, a significant portion (29%) of pharmacists strongly agreed that the facility’s board consistently provides clinical pharmacists with the necessary training to enhance their knowledge and expertise. Additionally, 35.5% of respondents agreed that effective communication between physicians, clinical pharmacists, and nurses is consistently maintained. Furthermore, 45.2% of clinical pharmacists expressed strong agreement with the requirement to submit a monthly medication error report to their facility’s board. Similarly, 41.9% of the included pharmacists strongly agreed that the facility’s board supports their recommendations aimed at reducing medication errors within the facility.
FIG. 2: WORKFORCE AND STANDARD PROCEDURES OF DRUG FACILITIES EFFECT
In our study, we included medical errors that occurred between September 2021 and July 2022 based on predefined inclusion criteria. The data for this study were gathered from various wards within our hospital, as depicted in Fig. 3. Our study classified medication errors into various types, as outlined in Table 3. The data revealed that Omission Error was the most common type of medication error in the months of September (46.4%), November 2021 (32.4%), February 2022 (45.4%), March 2022 (68.5%), and April 2022 (58%). Improper dosage was the predominant medication error type in the months of May 2022 (54.5%), June 2022 (24.5%), and July 2022 (25.9%). Additionally, Wrong Frequency emerged as the most prevalent type of medication error in the months of October 2021 (24.3%), December 2021 (31.7%), January 2022 (32.7%), June 2022 (32.9%), and July 2022 (25.9%).
FIG. 3: THE NUMBER OF MEDICAL ERRORS REPORTED PER MONTH
Types of Medication error | Sep-21 | Oct-21 | Nov-21 | Dec-21 | Jan-22 | |||||
Omission error | 70 | 46.4% | 35 | 18.5% | 46 | 32.4% | 2 | 1.4% | 27 | 18.4% |
Improper dose (over, under, or extra dose) | 31 | 20.5% | 23 | 12.2% | 25 | 17.6% | 35 | 24.5% | 38 | 25.9% |
Wrong patient | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Wrong drug | 2 | 1.3% | 1 | 0.5% | 1 | 0.7% | 5 | 3.5% | 3 | 2.0% |
Wrong strength/concentration | 0 | 0.0% | 1 | 0.5% | 3 | 2.1% | 0 | 0.0% | 0 | 0.0% |
Wrong route | 1 | 0.7% | 2 | 1.1% | 2 | 1.4% | 6 | 4.2% | 0 | 0.0% |
Wrong frequency | 23 | 15.2% | 46 | 24.3% | 45 | 31.7% | 47 | 32.9% | 48 | 32.7% |
Wrong rate of infusion | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 1 | 0.7% | 0 | 0.0% |
Wrong duration | 18 | 11.9% | 14 | 7.4% | 9 | 6.3% | 32 | 22.4% | 18 | 12.2% |
Wrong dosage form | 0 | 0.0% | 2 | 1.1% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Wrong time of administration | 0 | 0.0% | 1 | 0.5% | 0 | 0.0% | 0 | 0.0% | 1 | 0.7% |
Deteriorated/expired technique | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Deteriorated/expired medication | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
Monitoring errors-clinical intervention or information | 0 | 0.0% | 1 | 0.5% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
TABLE 3: TYPES OF MEDICATION ERRORS PER MONTH
Types of medication
error |
Feb 2022 | Mar 2022 | April 2022 | May 2022 | June 2022 | July 2022 | Types of medication
error |
Feb 2022 | Mar 2022 | April 2022 | May 2022 | June 2022 |
Omission
error |
18.50% | 46 | 18.50% | 46 | 18.50% | 46 | 18.50% | 46 | 18.50% | 46 | 18.50% | 46 |
Improper dose (over, under, or extra dose) | 12.20% | 25 | 12.20% | 25 | 12.20% | 25 | 12.20% | 25 | 12.20% | 25 | 12.20% | 25 |
Wrong patient | 0.00% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% | 0 |
Wrong drug | 0.50% | 1 | 0.50% | 1 | 0.50% | 1 | 0.50% | 1 | 0.50% | 1 | 0.50% | 1 |
Wrong strength/
concentration |
0.50% | 3 | 0.50% | 3 | 0.50% | 3 | 0.50% | 3 | 0.50% | 3 | 0.50% | 3 |
Wrong route | 1.10% | 2 | 1.10% | 2 | 1.10% | 2 | 1.10% | 2 | 1.10% | 2 | 1.10% | 2 |
Wrong frequency |
24.30% |
45 |
24.30% |
45 |
24.30% |
45 |
24.30% |
45 |
24.30% |
45 |
24.30% |
45 |
Wrong rate
of infusion |
0.00% |
0 |
0.00% |
0 |
0.00% |
0 |
0.00% |
0 |
0.00% |
0 |
0.00% |
0 |
Wrong
duration |
7.40% |
9 |
7.40% |
9 |
7.40% |
9 |
7.40% |
9 |
7.40% |
9 |
7.40% |
9 |
Wrong
dosage form |
1.10% |
0 |
1.10% |
0 |
1.10% |
0 |
1.10% |
0 |
1.10% |
0 |
1.10% |
0 |
The results presented in Fig. 4 indicate that physician orders played a pivotal role in medication error occurrence throughout all months. This stage accounted for the highest percentage of errors, with figures ranging from 85% to 98.6%. Specifically, in September 2021 (88.7%), October 2021 (86%), November 2021 (95.8%), December 2021 (96.5%), January 2022 (98.6%), February 2022 (88.7%), March 2022 (86.2%), April 2022 (85%), May 2022 (96.5%), June 2022 (98.6%), and July 2022 (53.7%). In addition to physician orders, a few other stages were implicated but to a lesser extent. Transcription and the entering process were identified as contributing factors in September 2021 (3.3%) and February 2022 (5.3%). Administration process was highlighted in October 2021 (12.2%), November 2021 (2.1%), March 2022 (12.2%), April 2022 (9%), and July 2022 (25.9%). In June 2022 (5.4%) and December 2021 (3.5%), dispensing and drug delivery were identified as factors. Notably, no monitoring errors related to drug levels, allergies, interactions, or clinical aspects were detected during the study period.
FIG. 4: STAGES OF MEDICATION ERROR PER MONTH
FIG. 5: COMMITTED PERSONNEL OF MEDICAL ERRORS
Fig. 5 illustrates that physicians were the most frequently implicated personnel in medication errors when compared to other medical staff, with nurses ranking second and pharmacists occupying the third position after nurses. No other medical staff members were found to be involved in committing medication errors during the study period.
In the current study, medication errors were categorized into eight subtypes based on their outcomes as follows: (A) circumstances/events with the potential to cause an error; (b) errors that occurred but did not reach the patient (near misses); (c) errors that occurred but did not result in harm; (d) errors that reached the patient and required monitoring; (e) errors that reached the patient and resulted in temporary harm, necessitating intervention; (f) errors that reached the patient and resulted in permanent harm; and (g) errors that reached the patient and required life-sustaining intervention. The data revealed that during the study period, the majority of reported and detected outcomes of errors fell into Category B, where errors did not reach the patient (96%). Category C, which included errors that reached the patient but did not cause harm, accounted for 3% of the cases, while Category A, which represented circumstances or events with the potential to cause an error, constituted 1% of the cases Fig. 6.
FIG. 6: MEDICATION ERROR OUTCOMES PER MONTH
Table 4 presents the distribution of reported medication errors, with the majority of errors being reported by pharmacists, followed by nurses. Specifically, in September 2021, pharmacists reported 115 errors, while nurses reported 36 errors. In subsequent months, the pattern continued, with pharmacists reporting the majority of errors: October 2021 (140), November 2021 (125), December 2021 (157), January 2022 (145), February 2022 (116), March 2022 (140), April 2022 (169), May 2022 (155), June 2022 (145), and July 2022 (141). On the other hand, nurses reported a smaller number of errors in the following months: October 2021 (49), November 2021 (17), January 2022 (2), February 2022 (26), March 2022 (3), April 2022 (17), June 2022 (12), and July 2022 (2). Notably, no medication errors were reported by nurses in December 2021 and May 2022.
TABLE 4: MEDICAL ERRORS WERE REPORTED ACROSS MONTHS
Medication Error Reported by: | Sep-21 | Oct-21 | Nov-21 | Dec-21 | Jan-22 | |||||||
Nurse | 36 | 23.8% | 49 | 25.9% | 17 | 12.0% | 0 | 0% | 2 | 1.4% | ||
Pharmacist | 115 | 76.2% | 140 | 74.1% | 125 | 88.0% | 157 | 100% | 145 | 98.6% | ||
Physician | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0% | 0 | 0.0% | ||
Dentist | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0% | 0 | 0.0% | ||
Patient/Caregiver | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0% | 0 | 0.0% | ||
RAD/ RT/ LAB | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0% | 0 | 0.0% | ||
Medication Error Reported by: | Feb-22 | Mar-22 | Apr-22 | May-22 | Jun-22 | |||||||
Nurse | 26 | 23.8% | 3 | 2.9% | 17 | 12.0% | 0 | 0% | 12 | 4.4% | ||
Pharmacist | 116 | 76.2% | 140 | 97.1% | 169 | 88.0% | 155 | 100% | 145 | 95.6% | ||
Physician | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0% | 0 | 0.0% | ||
Dentist | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0% | 0 | 0.0% | ||
Patient/Caregiver | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0% | 0 | 0.0% | ||
RAD/ RT/ LAB | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0% | 0 | 0.0% | ||
Reported by: | Jul | |||||||||||
Nurse | 2 | 1.4% | ||||||||||
Pharmacist | 141 | 98.6% | ||||||||||
Physician | 0 | 0.0% | ||||||||||
Dentist | 0 | 0.0% | ||||||||||
Patient/Caregiver | 0 | 0.0% | ||||||||||
RAD/ RT/ LAB | 0 | 0.0% |
The data collected during the study period revealed various causes for the occurrence of medication errors Fig. 7. It is evident that the miscommunication of drug orders (due to illegibility, ambiguity, or incompleteness) was the primary cause of medication errors in all the months under investigation. The potential causes of medical errors and contributing factors that led to these errors included the following: Lack of staff experience, accounting for 40% of the cases; staffing or workflow-related factors, such as staff shortages and high workloads, contributing to 30% of the errors; incorrect labeling of medications, which accounted for 10% of the errors; environmental factors, comprising 20% of the contributing factors and distributed equally among various environmental aspects, including lighting, noise, interruptions, and small or crowded working areas; and attitude-related elements from staff, patients, and caregivers also played a role in medication errors.
FIG. 7: CAUSES OF MEDICATION ERRORS
Pharmacists’ interventions aimed at reducing medical errors are illustrated in Fig. 8. The most common interventions included contacting the physician to verify emergency orders, followed by refraining from dispensing drugs to the patient and correcting the dose to the appropriate one. Upon detecting errors, pharmacists took a series of actions, starting with reporting the error to the area supervisor or in-charge. Subsequently, they would contact the physician to complete any missing information and notify the individual responsible for the mistake to correct it and prevent its recurrence. Additionally, efforts were made to arrange for further training programs to prevent the recurrence of reported errors.
FIG. 8: INTERVENTIONS FOR MEDICAL ERRORS
DISCUSSION: Medication errors are a significant contributor to patient morbidity and mortality. According to a report from the Institute of Medicine, medication errors are responsible for one out of every 131 outpatient deaths and one out of every 854 inpatient deaths 18.
The purpose of the current study was to assess the efforts of pharmacists in reporting and preventing medication errors at King Faisal Hospital in Makkah, Saudi Arabia. A total of 45 pharmacists participated in this study, and our findings indicated that the most common cause of medication errors detected in our hospital was attributed to various defects in the prescribing process.
In a separate study conducted in Tehran, Iran, clinical pharmacists reported 112 medication errors, which were primarily linked to errors in drug dosing, drug selection, drug administration, or drug interactions 9. Our study revealed that the majority of the participating pharmacists strongly agreed on the crucial role of pharmacists in checking for medication interactions between the prescribed medication and the patient’s existing medications listed in their medical history. They also unanimously acknowledged that a lack of knowledge about the prescribed medication, its accurate dosage, and the patient’s medical condition contributed significantly to medication errors.
A prospective study conducted in the United Kingdom over a span of 4 weeks supported our findings, indicating that one of the factors contributing to prescribing errors was the prescriber’s knowledge of the medication. In this study, it was observed that 5% of errors were related to prescribing, with 58% of these errors stemming from prescribing decisions and 42% resulting from issues with medication order writing 17.
The participating pharmacists identified several common barriers that could impede their efforts. The inadequate number of clinical pharmacists in their hospital and the lack of support from other clinical pharmacists or certain physicians were frequently cited as hindrances. Analysis of the questionnaire data revealed that our pharmacists are cognizant of their responsibilities and roles in detecting, reporting, and preventing drug-related problems (DRPs). A Saudi study also affirmed the vital role of pharmacists in reducing the incidence of DRPs, underscoring the significance of an optimized pharmaceutical care plan within clinical care settings 4.
Throughout the study period, the primary culprits behind medication errors at our hospital were omission errors during the prescribing phase and miscommunication of drug orders, often due to illegibility, ambiguity, or incompleteness. In line with our findings, a study conducted at King Khalid University Hospital, Kingdom of Saudi Arabia, identified incorrect drug strength and improper administration routes as the most prevalent types of prescribing errors, accounting for 35% and 23% of cases, respectively. These errors were primarily attributed to a lack of proficiency in prescribing skills 1.
In alignment with our study’s emphasis on the pivotal role of pharmacists in preventing DRPs, 14 highlighted the significant benefits of clinical pharmacist interventions, particularly in correcting prescribing errors related to dosing inaccuracies, units of measurement, route of administration, and dosing frequency 14.
Furthermore, the inclusion of pharmacists in critical care units has been shown to contribute to a reduction in medication error rates. The presence of an on-site pharmacist can help mitigate the occurrence of adverse drug reactions, particularly when drug dosages are meticulously adjusted to align with the functioning of the body’s elimination organs 6.
CONCLUSION: Most medication errors were committed by physicians. However, it’s worth noting that the majority of medication errors were reported by pharmacists. The most prevalent causes of these errors included prescribing, dispensing, dosing, omission errors, improper doses, and incorrect frequencies. Additionally, miscommunication of drug orders, often due to illegibility, ambiguity, or incompleteness, was identified as a critical factor contributing to medication errors in hospitals. Pharmacists took various interventions to reduce these medical errors. These interventions included actions such as calling physicians for verification in cases of emergency orders, discontinuing medications, dispensing medications to patients, and correcting incorrect dosages to the appropriate ones. Finally, the entire healthcare team should collectively shoulder the responsibility of ensuring optimal medication administration for patients to uphold best practices. Future studies should delve deeper into the various factors that contribute to a higher likelihood of encountering medication administration errors within hospital settings.
ACKNOWLEDGMENTS: We would like to express our gratitude to our colleagues at King Faisal Hospital in Makkah, as well as to the Ministry of Health and IRB-Makkah within the Makkah Healthcare Cluster, for their invaluable support throughout this study.
Funding for the Study: The study received no financial support from any organization.
CONFLICT OF INTEREST: The authors affirm that they have no conflicts of interest related to the publication of this paper.
REFERENCES:
- Al-Dhawailie AA: Inpatient prescribing errors and pharmacist intervention at a teaching hospital in Saudi Arabia. Saudi Pharmaceutical Journal 2011; 19(3): 193-96.
- Aldhwaihi K, Schifano F, Pezzolesi C and Umaru N: A systematic review of the nature of dispensing errors in hospital pharmacies. Integrated Pharmacy Research & Practice 2016; 5: 1-10.
- Alsulami Z, Conroy S and Choonara I: Medication errors in the Middle East countries: a systematic review of the literature. European Journal of Clinical Pharmacology 2013; 69(4): 995-1008.
- Babelghaith SD, Wajid S, Alrabiah Z, Othiq MAM, Alghadeer S, Alhossan A, Al-Arifi M and Attafi IM: Drug-related problems and pharmacist intervention at a general hospital in the Jazan Region, Saudi Arabia. Risk Management and Healthcare Policy 2020; 13: 373-378.
- Cousins DD and Heath WM: The National Coordinating Council for Medication Error Reporting and Prevention: promoting patient safety and quality through innovation and leadership. Joint Commission Journal on Quality and Patient Safety 2008; 34(12): 700–702.
- D’Errico S, Zanon M, Radaelli D, Padovano M, Santurro A, Scopetti M, Frati P and Fineschi V: Medication errors in pediatrics: proposals to improve the quality and safety of care through clinical risk management. Frontiers in Medicine 2021; 8: 814100.
- Elashwah M: Medication errors in ambulatory paediatric patient setting-: How close, or far, are we from an error free process? Infectious Disorders Drug Targets 2014; 14(3): 191–204.
- Elden NMK and Ismail A: The importance of medication errors reporting in improving the quality of clinical care services. Global Journal of Health Science 2016; 8(8): 243.
- Khalili H, Farsaei S, Rezaee H and Dashti-Khavidaki S: Role of clinical pharmacists’ interventions in detection and prevention of medication errors in a medical ward. International J of Clinical Pharmacy 2011; 33(2): 281–284.
- Maaskant JM, Vermeulen H, Apampa B, Fernando B, Ghaleb MA, Neubert A, Thayyil S and Soe A: Interventions for reducing medication errors in children in hospital. The Cochrane Database of Systematic Reviews. 2015; 3: CD006208.
- Mack PF: Medication safety in nonoperating room anesthesiology. Current Opinion in Anaesthesiology 2021; 34(4): 443–448.
- Mira JJ, Lorenzo S, Guilabert M, Navarro I and Pérez-Jover V: A systematic review of patient medication error on self-administering medication at home. Expert Opinion on Drug Safety 2015; 14(6): 815–838.
- Nanji KC: Perioperative medication error prevention. Current Anesthesiology Reports 2020; 10(3): 251–258.
- Naseralallah LM, Hussain TA, Jaam M and Pawluk SA: Impact of pharmacist interventions on medication errors in hospitalized pediatric patients: a systematic review and meta-analysis. International Journal of Clinical Pharmacy 2020; 42(4): 979–994.
- Tariq RA, Vashisht R, Sinha A and Scherbak Y: Medication Dispensing Errors and Prevention 2023.
- Medication errors: technical series on safer primary care. drug safety in developing countries: achievements and challenges. World Health Organization. 2016.
- Williams D: The classification of medication errors. Journal-Royal College of Physicians of Edinburgh 2007; 37(4): 343–346.
- Wittich CM, Burkle CM and Lanier WL: Medication errors: An overview for clinicians. Mayo Clinic Proceedings 2014; 89(8): 1116–1125.
How to cite this article:
Alsharif RM, Alharbi HB and Aleshemy KR: Pharmacist’s role in reporting and preventing medication errors at a general hospital in Makkah, Saudi Arabia. Int J Pharm Sci & Res 2024; 15(3): 874-83. doi: 10.13040/IJPSR.0975-8232.15(3).874-83.
All © 2024 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
30
874-883
805 KB
276
English
IJPSR
Reema Mashhour Alsharif *, Haneen Badi Alharbi and Khalid R. A. Abdellatif
Department of Clinical Pharmacy, King Faisal Hospital, Makkah, Saudi Arabia.
dr.reema@windowslive.com
01 August 2023
22 October 2023
30 December 2023
10.13040/IJPSR.0975-8232.15(3).874-83
01 March 2024